Elevance Health, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Elevance Health, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2010 to Q3 2024.
  • Elevance Health, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $365M, a 3.11% increase year-over-year.
  • Elevance Health, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $1.91B, a 10.9% increase year-over-year.
  • Elevance Health, Inc. annual Income Tax Expense (Benefit) for 2023 was $1.72B, a 0.7% increase from 2022.
  • Elevance Health, Inc. annual Income Tax Expense (Benefit) for 2022 was $1.71B, a 7.26% decline from 2021.
  • Elevance Health, Inc. annual Income Tax Expense (Benefit) for 2021 was $1.85B, a 10.8% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $1.91B $365M +$11M +3.11% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-17
Q2 2024 $1.9B $685M +$100M +17.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-17
Q1 2024 $1.8B $690M +$75M +12.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-18
Q4 2023 $1.72B $170M +$2M +1.19% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-21
Q3 2023 $1.72B $354M -$175M -33.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-17
Q2 2023 $1.9B $585M +$97M +19.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-17
Q1 2023 $1.8B $615M +$88M +16.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-18
Q4 2022 $1.71B $168M -$123M -42.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-21
Q3 2022 $1.84B $529M +$35M +7.09% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-18
Q2 2022 $1.8B $488M -$64M -11.6% Apr 1, 2022 Jun 30, 2022 10-Q/A 2023-09-29
Q1 2022 $1.86B $527M +$18M +3.54% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-19
Q4 2021 $1.85B $291M +$231M +385% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-21
Q3 2021 $1.62B $494M +$327M +196% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-19
Q2 2021 $1.29B $552M -$321M -36.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-20
Q1 2021 $1.61B $509M -$57M -10.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-20
Q4 2020 $1.67B $60M -$104M -63.4% Oct 1, 2020 Dec 31, 2020 10-Q 2023-10-18
Q3 2020 $1.77B $167M -$139M -45.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-20
Q2 2020 $1.91B $873M +$559M +178% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-21
Q1 2020 $1.35B $566M +$172M +43.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-21
Q4 2019 $1.18B $164M +$46M +39% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-16
Q3 2019 $1.13B $306M +$24M +8.51% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-28
Q2 2019 $1.11B $314M -$136M -30.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-29
Q1 2019 $1.24B $394M -$74M -15.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-29
Q4 2018 $1.32B $118M +$1.22B Oct 1, 2018 Dec 31, 2018 10-K 2021-02-18
Q3 2018 $93.5M $282M -$90M -24.2% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-23
Q2 2018 $184M $450M +$99.6M +28.4% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-24
Q1 2018 $83.9M $468M -$37.1M -7.35% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-24
Q4 2017 $121M -$1.11B -$1.4B -482% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-19
Q3 2017 $1.52B $372M -$147M -28.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-31
Q2 2017 $1.66B $350M -$317M -47.5% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-25
Q1 2017 $1.98B $505M -$104M -17.1% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-25
Q4 2016 $2.09B $290M +$96.2M +49.7% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-20
Q3 2016 $1.99B $519M +$43.9M +9.25% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-25
Q2 2016 $1.94B $668M -$31.2M -4.46% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-26
Q1 2016 $1.98B $609M -$94.9M -13.5% Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-26
Q4 2015 $2.07B $193M -$187M -49.2% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-21
Q3 2015 $2.26B $475M +$18.5M +4.05% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-02
Q2 2015 $2.24B $699M +$166M +31.2% Apr 1, 2015 Jun 30, 2015 10-Q 2016-07-27
Q1 2015 $2.07B $704M +$265M +60.5% Jan 1, 2015 Mar 31, 2015 10-Q 2016-04-27
Q4 2014 $1.81B $380M +$219M +136% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-22
Q3 2014 $1.59B $456M +$230M +102% Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-28
Q2 2014 $1.36B $533M +$124M +30.3% Apr 1, 2014 Jun 30, 2014 10-Q 2015-07-29
Q1 2014 $1.23B $439M +$28.5M +6.95% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-29
Q4 2013 $1.21B $161M +$147M +1010% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-19
Q3 2013 $1.06B $226M -$109M -32.5% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-29
Q2 2013 $1.17B $409M +$3.8M +0.94% Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-30
Q1 2013 $1.16B $410M -$43.1M -9.51% Jan 1, 2013 Mar 31, 2013 10-Q 2014-04-30
Q4 2012 $1.21B $14.5M -$128M -89.9% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-24
Q3 2012 $1.34B $335M -$27.5M -7.6% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-23
Q2 2012 $1.36B $405M +$99.2M +32.4% Apr 1, 2012 Jun 30, 2012 10-Q 2013-07-24
Q1 2012 $1.26B $453M -$47.2M -9.43% Jan 1, 2012 Mar 31, 2012 10-Q 2013-04-24
Q4 2011 $1.31B $143M -$60.4M -29.7% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-20
Q3 2011 $1.37B $362M -$35.7M -8.98% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-07
Q2 2011 $1.41B $306M -$101M -24.9% Apr 1, 2011 Jun 30, 2011 10-Q 2012-07-25
Q1 2011 $1.51B $501M +$42M +9.16% Jan 1, 2011 Mar 31, 2011 10-Q 2012-04-25
Q4 2010 $1.47B $203M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-22
Q3 2010 $398M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-26
Q2 2010 $407M Apr 1, 2010 Jun 30, 2010 10-Q 2011-07-27
Q1 2010 $459M Jan 1, 2010 Mar 31, 2010 10-Q 2011-04-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.